Olezarsen now covers severe hypertriglyceridemia; plozasiran remains FCS-only. Neha Pagidipati, MD, on what the split means for practice.

Nearly a decade ago, a landmark trial of deep brain stimulation for depression failed to show efficacy. Now researchers are ...

A ‘living’ evidence review of bipolar disorder treatments has been transformed into a free, continuously updated online tool ...

Propofol infusion may not offer better 30-day recovery or survival outcomes after major noncardiac surgery compared with ...

Many adults on GLP-1s maintain their weight loss at 2 years. Full return to baseline weight is found to be rare.

About one1 in five5 patients with adrenal incidentalomas hadve changes in cortisol status over time, suggesting that routine ...

Hyponatraemia during the first 72 hours of life is linked to later neurodevelopmental disorders or death in infants with ...

Ankle strength shows no clear association with foot posture or general joint hypermobility in children, with only weak links ...

Opioid use disorder is associated with a higher risk for complications before discharge after inpatient removal of the uterus ...

Adding doravirine to an existing antiretroviral regimen helps people living with HIV regain virologic control, especially ...

When added to semaglutide or placebo, glucose-dependent insulinotropic polypeptide (GIP) shows no effect on glycemic control ...

An analysis using data from three long-running studies on the effect of lifestyle and health provides more support for ...